Intraocular Inflammation Clinical Trial
Official title:
A US Real-World Evidence Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022
Specific study objectives include: - To describe patient and provider characteristics for aflibercept patients and aflibercept user injections by aflibercept dispensing device, overall, and stratified by time (quarterly, annually). - To estimate the annual and quarterly incidence of intraocular inflammation (IOI) and suspected endophthalmitis for aflibercept user injections by aflibercept dispensing device. Secondary objectives • To estimate the annual incidence of IOI and suspected endophthalmitis for aflibercept user injections by dispensing device, stratified by indication for use, history of IOI, and provider characteristics.
This study is entirely descriptive using secondary data from the Vestrum Health Retina Treatment and Outcomes database. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01384266 -
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
|
N/A | |
| Active, not recruiting |
NCT04914884 -
Intraocular Fluid Detection in Endophthalmitis
|
||
| Completed |
NCT05657158 -
Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
|
||
| Withdrawn |
NCT00958906 -
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
|
Phase 1/Phase 2 |